Concepedia

Bret R. Umstead

BR

3

Publications

303

Citations

3

H-Index

2017

Active since

Affiliations

PhaseBio Pharmaceuticals (United States)(Current)

Thrombosis and Atherosclerosis Research Institute

Brigham and Women's Hospital

Harvard University

McMaster University

Bret R. Umstead is an author at PhaseBio Pharmaceuticals (United States) specializing in biochemical engineering, biotechnology, and engineering.

ORCID

Top concepts

Publications per year

2017–2021

3

Publications

3

Antibody-Based Ticagrelor Reversal Agent in Healthy Volunteers

Deepak L. Bhatt, Charles V. Pollack, Jeffrey I. Weitz et al. · New England Journal of Medicine · 2019 · 131 citations · Full text

One-week glucose control via zero-order release kinetics from an injectable depot of glucagon-like peptide-1 fused to a thermosensitive biopolymer

Kelli M. Luginbuhl, Jeffrey L. Schaal, Bret R. Umstead et al. · Nature Biomedical Engineering · 2017 · 122 citations · Full text

, , +6

Bentracimab for Ticagrelor Reversal in Patients Undergoing Urgent Surgery

Deepak L. Bhatt, Charles V. Pollack, C. David Mazer et al. · NEJM Evidence · 2021 · 50 citations · Full text

, , +19

Rows per page

1–3 of 3